LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +19.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +5 | 56.58M | $15.83B | +9 | −3 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | — | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | — |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | — | 5.93M | $1.21B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 3.70M | — | $849.30M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 2.00M | +2.0% | $458.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.00M | +2.0% | $458.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.43M | +968.7% | $328.02M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.43M | +968.7% | $328.02M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 1.05M | +0.5% | $239.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 704.77K | +303.2% | $161.62M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 117.84K | -0.3% | $27.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 117.84K | -0.3% | $27.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 55.77K | -9.4% | $12.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 42.64K | Nuevo | $9.78M | 0.0% | New | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 36.45K | -75.7% | $8.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 25.64K | Nuevo | $5.88M | 0.1% | New | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 2.03K | +62.8% | $466,254 | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Adage Capital Partners | $9.78M | 0.0% |
| Gotham Asset Management | $5.88M | 0.1% |
Posición cerrada
| Renaissance Technologies | $13.23M | era 0.0% |
| Marshall Wace | $6.24M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,014 tenedores, 76.41M acciones, $19.36B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 3.00K acc. · $954,060
Officer, Director · 4.67K acc. · $1.50M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología